ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.6 USD 20.3% Market Closed
Market Cap: 268.5m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Investor Relations

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Christian Angermayer
Founder & Chairman of the Supervisory Board
No Bio Available
Dr. Srinivas G. Rao M.D., Ph.D.
Co-Founder & Co-CEO
No Bio Available
Mr. Florian Brand
Co-Founder, MD & Co-CEO
No Bio Available
Ms. Anne Johnson
Chief Financial Officer
No Bio Available
Dr. Michael Raven Ph.D.
Senior Vice President of Operations
No Bio Available
Mr. Frank Stegert
Vice President of Investment & Venture Management
No Bio Available
Mr. Ryan Barrett J.D.
Senior VP, General Counsel & Corporate Secretary
No Bio Available
Dr. Glenn Short Ph.D.
Senior Vice President of Early Development
No Bio Available
Dr. Sahil V. Kirpekar M.D.
Chief Business Officer
No Bio Available
Dr. Kevin Craig M.D.
Senior Vice President of Clinical Development
No Bio Available

Contacts

Address
BERLIN
Berlin
c/o Mindspace, Krausenstrasse 9-10
Contacts
+498921539035.0
www.atai.life